logo
Select company
Select metric
$ -52.4MConsolidated Income
VS
Market
19
Sector
37
Industry
49
History
87
$ 33.56Close
$ 18.32 - $ 49.05 52-Week Range
Ticker Information

Ticker

LENZ

Company Name

LENZ THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

LENZ THERAPEUTICS INC - Consolidated Income Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

LENZ - Cons. Inc. Historical data
DateConsolidated Income
6/30/2025$ -52.4M
3/31/2025$ -47.74M
12/31/2024$ -49.77M
9/30/2024$ -60.03M
6/30/2024$ -72.31M
3/31/2024$ -117.36M
12/31/2023$ -124.65M
9/30/2023$ -126.33M
6/30/2023$ -128.53M
3/31/2023$ -99.15M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • LENZ THERAPEUTICS INC's latest trailing twelve months (TTM) Cons. Inc. stands at $ -68.37M.
  • Over the past 5 years, LENZ THERAPEUTICS INC's average Cons. Inc. has been $ -86.06M.
  • The median Cons. Inc. for LENZ THERAPEUTICS INC during this period was $ -81.4M
  • LENZ THERAPEUTICS INC reached its highest Cons. Inc. over the past 5 years at $ -47.74M.
  • The lowest Cons. Inc. recorded by LENZ THERAPEUTICS INC in the same timeframe $ -128.53M

LENZ THERAPEUTICS INC's Cons. Inc. vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cons. Inc. Benchmarks
CompanyCons. Inc.
DNTH : DIANTHUS THERAPEUTICS INC $ -114.75MPRME : PRIME MEDICINE INC $ -199.28MUPB : UPSTREAM BIO INC $ -104.47MPGEN : PRECIGEN INC $ -124.5MATAI : ATAI LIFE SCIENCES NV $ -119.51MABSI : ABSCI CORP $ -113.3MTSHA : TAYSHA GENE THERAPIES INC $ -92.72MOCGN : OCUGEN INC $ -56.94MCLDX : CELLDEX THERAPEUTICS INC $ -199.61MPRAX : PRAXIS PRECISION MEDICINES INC $ -251.01M

Similar metrics to Cons. Inc.:

Definition of Consolidated Income

[Income Statement] The portion of profit or loss for the period; net of income taxes; which is attributable to the consolidated entity; before the deduction of [NetIncNCI].

LENZ - Consolidated Income, Last 5 years

$ -128.53M

Minimum

Jun 30, 2023

$ -47.74M

Maximum

Mar 31, 2025

$ -86.06M

Average

$ -81.4M

Median

Cons. Inc. Benchmark Analysis

 The chart above depicts the distribution of Cons. Inc. for companies in the Total Stock Market. The average Cons. Inc. of the companies is $ 12.01M with a standard deviation of $ 116.51M.
The following table provides additional summary stats:
Cons. Inc. in the Market:
filtered constituents3.36K
min$ -363.1M
max$ 377.69M
average$ 12.01M
median$ -2.1M
std$ 116.51M